Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. Phase II- HazPrep Worker Training- Community Risk Profile

    SBC: Inxsol LLC            Topic: 142

    PROJECT SUMMARY ABSTRACT A workerandapos s personal hazard profilePHPis a function of hazards present and his her exposure level to those hazardsWorkers with an elevated level of risk are those who can be engaged in activities related toor working aroundhazardous materialswaste generationremovalcontainmenttransportationand emergency responseinXsol s Phase I feasibility study verified appeal and ef ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  2. Goldmann Contact Tonometry with Optimized Error Correction

    SBC: CATS Tonometer, LLC            Topic: NEI

    Intuor TechnologiesLLCProject Summary Goldmann Contact Tonometry with Optimized Error Correction Intraocular pressureIOPmeasurement is a very important criteria used to assess visual acuity when eye care professionals are diagnosingtreatingand managing potential glaucoma patientsGoldman tonometryGATIOP is recognized as thegold standardbut GAT IOP measurements errors have been identifiedPhase I res ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  3. Nano-Oscillator Arrays for Sensitive Plasmonic Detection of Molecular Interactions and Reactions

    SBC: BIOSENSING INSTRUMENT INC            Topic: 400

    ABSTRACT Detecting molecular interactions and reactions are basic tasks to understand biochemical processes in living organismsdiscover biomarkers and develop drugsTodayandapos s mainstream commercial detection technologies are based on measuring mass changeswhich struggle to detect small moleculese gmetaboliteshormonesand neurotransmittersand biochemical reactions involving small mass changese gp ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  4. A badge-like exposure device for occupational safety and epidemiological study

    SBC: TF HEALTH CORPORATION            Topic: 113

    Abstract Chemical exposure poses a threat to the safety and health of each of usespecially those who work in certain industriessuch as petroleum extraction and refinery facilitiesmining industryand fertilizer factoriesVarious sensing technologies have been developed over the past decades to address the needbut a low cost and accurate personal exposure device that can track multiple chemical pollut ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  5. Application of PPODA-QT for embolization of aneurysms

    SBC: Aneuvas Technologies, Inc.            Topic: 101

    PROJECT SUMMARY ABSTRACTA cerebral aneurysm is an abnormal enlargement or pouch that forms from a weakened vessel segment in the brainOften going unnoticed and untreatedan aneurysm can cause a sudden and catastrophic hemorrhage or strokeApproximatelyof patients die from an aneurysm rupture even before receiving medical attention andof patients die despite medical treatmentPatients that survive typ ...

    STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  6. Sustained release gel enabling one-stage treatment of prosthetic joint infection

    SBC: Sonoran Biosciences, Inc.            Topic: NIAID

    Prosthetic joint infectionsPJIsare a serious complication of total joint replacement surgeryPJIs accounted for about $billion in healthcare costs inUnfortunatelytreatment of PJI is under reimbursedand healthcare reforms are putting increasing economic pressure on hospitals to bear the high costs of treating these infectionsNew technologies are badly needed to improve the quality of care and costs ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  7. Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND

    SBC: Yaso Therapeutics Incorporated            Topic: NICHD

    Women in all economicsocialand cultural circumstances suffer from high rates of unplanned pregnancyalong with a high prevalence and incidence of sexually transmitted diseasesTrends in the United States and lesser developed economies are going in the wrong directionThe availability of a single multipurpose prevention productMPTthat prevents both unplanned pregnancy and one or more of the most preva ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  8. Low Voltage Radiation Hardened Optoelectronics for Optical Interconnects

    SBC: QUANTTERA LLC            Topic: DTRA152001

    The Defense Threat Reduction Agency (DTRA) recognizes the need for low-power high-bandwidth radiation-hard optical interconnects to process more data more quickly and to replace electronic data.Our companys core development in optical communications with semiconductor materials is a unique fit for DTRAs low-power consumption high-bandwidth radiation-hard intra-chip communication components for sat ...

    SBIR Phase II 2018 Department of DefenseDefense Threat Reduction Agency
  9. MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases

    SBC: Sanguine Diagnostics And Therapeutics, Inc.            Topic: 300

    Abstract The goal of this Fast track application is to develop a non invasive diagnostic testbased on MUCand MUCmucinsthat can serve as an adjunct to cytological analysis of fine needle aspiratesFNAsfor accurate prediction of malignancy in patients with cystic pancreatic lesionsDue to asymptomatic nature and lack of methods for early detectionandgtof pancreatic cancerPCpatients present with an unr ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  10. A Prognostic Blood Test to Monitor Pancreatic Cancer Treatment by MiRNA Profiling

    SBC: VAJRA INSTRUMENTS, INC.            Topic: 102

    Pancreatic ductal adenocarcinomaPDAChas ayear survival rate of less thanThe success in developing therapies for other cancers over the last two decades has not improved the dismal overall survivalOSrate for PDACIt is now becoming increasingly apparent that personalized medicine based on the genetics of a tumor will be essential for developing a treatment strategyThusthere is an urgent need to deve ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government